THERAVANCE BIOPHARMA INC's ticker is TBPH and the CUSIP is G8807B106. A total of 88 filers reported holding THERAVANCE BIOPHARMA INC in Q3 2017. The put-call ratio across all filers is 10.02 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $374,163 | -66.9% | 44,123 | -65.0% | 0.00% | – |
Q1 2024 | $1,129,332 | +55.3% | 125,901 | +94.6% | 0.00% | – |
Q4 2023 | $727,070 | -19.3% | 64,686 | -38.0% | 0.00% | – |
Q3 2023 | $900,808 | +64.7% | 104,381 | +97.5% | 0.00% | – |
Q2 2023 | $547,009 | -4.0% | 52,851 | +0.7% | 0.00% | – |
Q1 2023 | $569,647 | +77.5% | 52,502 | +83.6% | 0.00% | – |
Q4 2022 | $320,915 | +8.4% | 28,602 | -1.7% | 0.00% | – |
Q3 2022 | $296,000 | +24.4% | 29,098 | +10.7% | 0.00% | – |
Q2 2022 | $238,000 | -4.0% | 26,281 | +1.4% | 0.00% | – |
Q1 2022 | $248,000 | -12.7% | 25,908 | +0.7% | 0.00% | – |
Q4 2021 | $284,000 | +40.6% | 25,729 | -5.6% | 0.00% | – |
Q3 2021 | $202,000 | -36.3% | 27,252 | +24.9% | 0.00% | – |
Q2 2021 | $317,000 | +26.3% | 21,812 | +77.3% | 0.00% | – |
Q1 2021 | $251,000 | +40.2% | 12,304 | +22.6% | 0.00% | – |
Q4 2020 | $179,000 | -69.5% | 10,033 | -60.5% | 0.00% | – |
Q1 2020 | $587,000 | +96.3% | 25,408 | +92.6% | 0.00% | – |
Q1 2019 | $299,000 | -53.2% | 13,190 | -47.2% | 0.00% | – |
Q4 2018 | $639,000 | -24.5% | 24,978 | -3.6% | 0.00% | – |
Q3 2018 | $846,000 | +67.9% | 25,904 | +16.7% | 0.00% | – |
Q2 2018 | $504,000 | +80.6% | 22,204 | +92.9% | 0.00% | – |
Q1 2018 | $279,000 | +36.8% | 11,509 | +57.4% | 0.00% | – |
Q4 2017 | $204,000 | -89.5% | 7,311 | -87.1% | 0.00% | -100.0% |
Q3 2017 | $1,947,000 | +648.8% | 56,860 | +770.9% | 0.00% | – |
Q2 2017 | $260,000 | +7.9% | 6,529 | -0.4% | 0.00% | – |
Q1 2017 | $241,000 | -82.6% | 6,552 | -84.9% | 0.00% | – |
Q4 2016 | $1,384,000 | -57.6% | 43,411 | -51.8% | 0.00% | -100.0% |
Q3 2016 | $3,267,000 | +65240.0% | 90,152 | +24069.4% | 0.00% | – |
Q2 2015 | $5,000 | – | 373 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Chescapmanager LLC | 1,157,718 | $17,117,000 | 2.77% |
Baupost Group | 8,735,168 | $129,149,000 | 1.40% |
Orbimed Advisors | 6,219,110 | $91,950,000 | 1.16% |
Rubric Capital Management LP | 550,747 | $8,143,000 | 0.76% |
Cormorant Asset Management, LP | 650,072 | $9,611,000 | 0.37% |
Rock Springs Capital Management LP | 824,018 | $12,183,000 | 0.31% |
Virtus ETF Advisers LLC | 23,148 | $342,000 | 0.18% |
Tekla Capital Management LLC | 298,470 | $4,413,000 | 0.16% |
PEREGRINE CAPITAL MANAGEMENT LLC | 412,594 | $6,100,000 | 0.16% |
NJ State Employees Deferred Compensation Plan | 38,142 | $564,000 | 0.10% |